ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2026
Alzheimer's disease biological domain sub-stratification enhances the precision of functional analyses.
Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
introductionThe Target Enablement to Accelerate Therapy Development for AD (TREAT-AD) bioinformatics pipeline employs a rank-and-organize strategy. Disease-associated genes drive enrichment of large AD-linked endophenotypes. However, these biological areas were too large to promote hypothesis development or target identification. Here we delineate subdomains that map to, and enrich, specific biological processes.
methodsTo refine the biodomains into more focused areas, we built κ networks out of the Gene Ontology terms in the biodomain and employ shared gene annotation between terms to determine edge weights. κ-value filtration enabled us to identify data-driven subdomains, which we employed in an analysis of TREAT-AD harmonized datasets.
resultsThe subdomain enrichment highlights core areas of biological impairment within the biodomain space and facilitates a deeper interpretation of large-scale multiomic datasets. DISCUSSION: The subdomain mapping of AD-risk-associated processes may facilitate an open-source, open-science shareable resource for the comparison of large datasets for the formulation of future hypotheses and identification of therapeutic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.